As the population continues to age, the number of dementia cases in the UK could increase to rise to 1.5 million by 2040, a new study has predicted. The study report... Read More
Author: pharmacybiz
Challenges in accessing the NHS waiting list are pushing more and more people toward private-funded alternatives for access, diagnosis and treatment, thereby increasing the demand for private health cover. According to... Read More
The 14th Community Pharmacy Conference by Sigma Pharmaceuticals has been timely, prime minister Rishi Sunak said, noting that it coincided with the launch of Pharmacy First, a new initiative that... Read More
The hybrid professional and leadership session underscores the Sigma Conference’s significance in offering hope and inspiration to its delegates. This pioneering venture unfolds following meticulous planning, months of deliberation, and... Read More
Professor Mahendra Patel OBE, CEO of the Oxford University Centre for Research Equity (CfRE), has been appointed as an independent expert member of the UK Pharmacy Professional Leadership Advisory Board.... Read More
Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is “not in shape” to help Europe meet its public... Read More
In a bid to bolster the educational experience for undergraduate pharmacy students across London, Kingston University has embarked on a groundbreaking project in collaboration with University College London and King’s... Read More
The professional leadership body for pharmacists has urged the General Pharmaceutical Council’s (GPhC) to make it mandatory to have a chief pharmacist within organisations to ensure transparency for patients, the... Read More
In a significant move aimed at improving patient care and alleviating hospital pressures, the National Health Services (NHS) has expanded its same day emergency care services across the UK. This has resulted... Read More
Representatives from the National Pharmacy Association (NPA) and the Royal Pharmaceutical Society (RPS) presented their preliminary evidence to the Inquiry, which is examining the impact of the COVID-19 pandemic on... Read More